Vimian Group AB (publ) (VIMGF)

Market Cap	2.31B
Revenue (ttm)	422.61M
Net Income (ttm)	20.86M
Shares Out	n/a
EPS (ttm)	0.04
PE Ratio	110.97
Forward PE	33.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	125
Average Volume	5,736
Open	4.255
Previous Close	3.990
Day's Range	4.255 - 4.255
52-Week Range	3.150 - 4.500
Beta	1.56
RSI	51.34
Earnings Date	Jul 18, 2025

About Vimian Group AB

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the I...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2020
• Employees: 1,200
• Stock Exchange: OTCMKTS
• Ticker Symbol: VIMGF

Financial Performance

In 2024, Vimian Group AB's revenue was 374.80 million, an increase of 12.99% compared to the previous year's 331.70 million. Earnings were 18.50 million, an increase of 88.78%.

Financial numbers in EUR